Cargando…
Correction: An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial Therapy
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938098/ https://www.ncbi.nlm.nih.gov/pubmed/27391807 http://dx.doi.org/10.1371/journal.pone.0159286 |
| _version_ | 1782441811361398784 |
|---|---|
| author | Llibre, Josep M. Raffi, François Moyle, Graeme Behrens, Georg Bouee, Stephane Reilly, Geraldine Borg, Peter Piontkowsky, David Rogatto, Felipe |
| author_facet | Llibre, Josep M. Raffi, François Moyle, Graeme Behrens, Georg Bouee, Stephane Reilly, Geraldine Borg, Peter Piontkowsky, David Rogatto, Felipe |
| author_sort | Llibre, Josep M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4938098 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Public Library of Science |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-49380982016-07-22 Correction: An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial Therapy Llibre, Josep M. Raffi, François Moyle, Graeme Behrens, Georg Bouee, Stephane Reilly, Geraldine Borg, Peter Piontkowsky, David Rogatto, Felipe PLoS One Correction Public Library of Science 2016-07-08 /pmc/articles/PMC4938098/ /pubmed/27391807 http://dx.doi.org/10.1371/journal.pone.0159286 Text en © 2016 Llibre et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Correction Llibre, Josep M. Raffi, François Moyle, Graeme Behrens, Georg Bouee, Stephane Reilly, Geraldine Borg, Peter Piontkowsky, David Rogatto, Felipe Correction: An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial Therapy |
| title | Correction: An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial Therapy |
| title_full | Correction: An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial Therapy |
| title_fullStr | Correction: An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial Therapy |
| title_full_unstemmed | Correction: An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial Therapy |
| title_short | Correction: An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial Therapy |
| title_sort | correction: an indirect comparison of efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate and abacavir/lamivudine + dolutegravir in initial therapy |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938098/ https://www.ncbi.nlm.nih.gov/pubmed/27391807 http://dx.doi.org/10.1371/journal.pone.0159286 |
| work_keys_str_mv | AT llibrejosepm correctionanindirectcomparisonofefficacyandsafetyofelvitegravircobicistatemtricitabinetenofovirdisoproxilfumarateandabacavirlamivudinedolutegravirininitialtherapy AT raffifrancois correctionanindirectcomparisonofefficacyandsafetyofelvitegravircobicistatemtricitabinetenofovirdisoproxilfumarateandabacavirlamivudinedolutegravirininitialtherapy AT moylegraeme correctionanindirectcomparisonofefficacyandsafetyofelvitegravircobicistatemtricitabinetenofovirdisoproxilfumarateandabacavirlamivudinedolutegravirininitialtherapy AT behrensgeorg correctionanindirectcomparisonofefficacyandsafetyofelvitegravircobicistatemtricitabinetenofovirdisoproxilfumarateandabacavirlamivudinedolutegravirininitialtherapy AT boueestephane correctionanindirectcomparisonofefficacyandsafetyofelvitegravircobicistatemtricitabinetenofovirdisoproxilfumarateandabacavirlamivudinedolutegravirininitialtherapy AT reillygeraldine correctionanindirectcomparisonofefficacyandsafetyofelvitegravircobicistatemtricitabinetenofovirdisoproxilfumarateandabacavirlamivudinedolutegravirininitialtherapy AT borgpeter correctionanindirectcomparisonofefficacyandsafetyofelvitegravircobicistatemtricitabinetenofovirdisoproxilfumarateandabacavirlamivudinedolutegravirininitialtherapy AT piontkowskydavid correctionanindirectcomparisonofefficacyandsafetyofelvitegravircobicistatemtricitabinetenofovirdisoproxilfumarateandabacavirlamivudinedolutegravirininitialtherapy AT rogattofelipe correctionanindirectcomparisonofefficacyandsafetyofelvitegravircobicistatemtricitabinetenofovirdisoproxilfumarateandabacavirlamivudinedolutegravirininitialtherapy |